Quantitative Evaluation of Morphological Changes in Activated Platelets in Vitro Using Digital Holographic Microscopy
Overview
Authors
Affiliations
Platelet activation and aggregation have been conventionally evaluated using an aggregometer. However, this method is suitable for short-term but not long-term quantitative evaluation of platelet aggregation, morphological changes, and/or adhesion to specific materials. The recently developed digital holographic microscopy (DHM) has enabled the quantitative evaluation of cell size and morphology without labeling or destruction. Thus, we aim to validate its applicability in quantitatively evaluating changes in cell morphology, especially in the aggregation and spreading of activated platelets, thus modifying typical image analysis procedures to suit aggregated platelets. Freshly prepared platelet-rich plasma was washed with phosphate-buffered saline and treated with 0.1% CaCl. Platelets were then fixed and subjected to DHM, scanning electron microscopy (SEM), atomic force microscopy, optical microscopy, and flow cytometry (FCM). Tightly aggregated platelets were identified as single cells. Data obtained from time-course experiments were plotted two-dimensionally according to the average optical thickness versus attachment area and divided into four regions. The majority of the control platelets, which supposedly contained small and round platelets, were distributed in the lower left region. As activation time increased, however, this population dispersed toward the upper right region. The distribution shift demonstrated by DHM was essentially consistent with data obtained from SEM and FCM. Therefore, DHM was validated as a promising device for testing platelet function given that it allows for the quantitative evaluation of activation-dependent morphological changes in platelets. DHM technology will be applicable to the quality assurance of platelet concentrates, as well as diagnosis and drug discovery related to platelet functions.
Dohet-Eraly J, Boudjeltia K, Rousseau A, Queeckers P, Lelubre C, Desmet J Biomed Opt Express. 2022; 13(1):502-513.
PMID: 35154888 PMC: 8803030. DOI: 10.1364/BOE.448817.
The Platelet Concentrates Therapy: From the Biased Past to the Anticipated Future.
Kawase T, Mubarak S, Mourao C Bioengineering (Basel). 2020; 7(3).
PMID: 32751638 PMC: 7552713. DOI: 10.3390/bioengineering7030082.
Aizawa H, Kawabata H, Sato A, Masuki H, Watanabe T, Tsujino T Biomedicines. 2020; 8(3).
PMID: 32106422 PMC: 7148468. DOI: 10.3390/biomedicines8030042.
Tsujino T, Takahashi A, Watanabe T, Isobe K, Kitamura Y, Okuda K Dent J (Basel). 2019; 7(4).
PMID: 31752355 PMC: 6960926. DOI: 10.3390/dj7040109.
Tsujino T, Isobe K, Kawabata H, Aizawa H, Yamaguchi S, Kitamura Y Dent J (Basel). 2019; 7(2).
PMID: 31163628 PMC: 6631196. DOI: 10.3390/dj7020061.